
Genmab A/S
CSE:GMAB

Balance Sheet
Balance Sheet Decomposition
Genmab A/S
Current Assets | 27.9B |
Cash & Short-Term Investments | 21.1B |
Receivables | 6.7B |
Other Current Assets | 62m |
Non-Current Assets | 18B |
Long-Term Investments | 228m |
PP&E | 1.9B |
Intangibles | 14.9B |
Other Non-Current Assets | 960m |
Balance Sheet
Genmab A/S
Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
874
|
307
|
1 348
|
533
|
3 552
|
7 260
|
8 957
|
9 893
|
14 867
|
9 858
|
|
Cash Equivalents |
874
|
307
|
1 348
|
533
|
3 552
|
7 260
|
8 957
|
9 893
|
14 867
|
9 858
|
|
Short-Term Investments |
2 619
|
3 615
|
4 075
|
5 573
|
7 419
|
8 819
|
10 381
|
12 431
|
13 268
|
11 243
|
|
Total Receivables |
175
|
976
|
637
|
1 327
|
2 990
|
2 712
|
3 398
|
5 894
|
4 947
|
6 691
|
|
Accounts Receivables |
175
|
976
|
579
|
1 327
|
2 990
|
2 463
|
3 367
|
5 712
|
4 947
|
6 590
|
|
Other Receivables |
0
|
0
|
58
|
0
|
0
|
249
|
31
|
182
|
0
|
101
|
|
Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
57
|
62
|
|
Total Current Assets |
3 668
|
4 898
|
6 059
|
7 433
|
13 961
|
18 791
|
22 736
|
28 218
|
33 139
|
27 854
|
|
PP&E Net |
29
|
32
|
113
|
162
|
414
|
736
|
975
|
1 322
|
1 641
|
1 891
|
|
PP&E Gross |
29
|
32
|
113
|
162
|
414
|
736
|
975
|
1 322
|
1 641
|
1 891
|
|
Accumulated Depreciation |
129
|
132
|
135
|
151
|
189
|
264
|
368
|
495
|
676
|
837
|
|
Intangible Assets |
193
|
182
|
124
|
470
|
470
|
338
|
254
|
146
|
101
|
12 343
|
|
Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 535
|
|
Note Receivable |
7
|
1
|
9
|
10
|
11
|
20
|
27
|
48
|
62
|
52
|
|
Long-Term Investments |
0
|
0
|
0
|
0
|
149
|
1 081
|
371
|
133
|
134
|
228
|
|
Other Long-Term Assets |
6
|
125
|
297
|
386
|
139
|
177
|
264
|
252
|
212
|
908
|
|
Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 535
|
|
Total Assets |
3 903
N/A
|
5 238
+34%
|
6 603
+26%
|
8 461
+28%
|
15 144
+79%
|
21 143
+40%
|
24 627
+16%
|
30 119
+22%
|
35 289
+17%
|
45 811
+30%
|
|
Liabilities | |||||||||||
Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
350
|
245
|
330
|
644
|
|
Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
296
|
481
|
637
|
720
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
26
|
42
|
62
|
74
|
90
|
92
|
|
Other Current Liabilities |
414
|
412
|
327
|
443
|
912
|
1 211
|
860
|
1 023
|
1 427
|
3 852
|
|
Total Current Liabilities |
414
|
412
|
327
|
443
|
938
|
1 253
|
1 568
|
1 823
|
2 484
|
5 308
|
|
Long-Term Debt |
0
|
0
|
0
|
0
|
155
|
277
|
363
|
523
|
680
|
937
|
|
Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 359
|
|
Other Liabilities |
1
|
0
|
4
|
3
|
3
|
492
|
500
|
491
|
515
|
510
|
|
Total Liabilities |
416
N/A
|
412
-1%
|
331
-20%
|
447
+35%
|
1 096
+145%
|
2 022
+84%
|
2 431
+20%
|
2 837
+17%
|
3 679
+30%
|
9 114
+148%
|
|
Equity | |||||||||||
Common Stock |
60
|
60
|
61
|
61
|
65
|
66
|
66
|
66
|
66
|
66
|
|
Retained Earnings |
4 228
|
3 003
|
1 855
|
197
|
2 130
|
7 107
|
10 020
|
14 809
|
19 023
|
23 551
|
|
Additional Paid In Capital |
7 561
|
7 770
|
7 984
|
8 059
|
11 755
|
11 894
|
12 029
|
12 309
|
12 461
|
12 590
|
|
Other Equity |
94
|
0
|
82
|
92
|
98
|
54
|
81
|
98
|
60
|
490
|
|
Total Equity |
3 487
N/A
|
4 827
+38%
|
6 272
+30%
|
8 014
+28%
|
14 048
+75%
|
19 121
+36%
|
22 196
+16%
|
27 282
+23%
|
31 610
+16%
|
36 697
+16%
|
|
Total Liabilities & Equity |
3 903
N/A
|
5 238
+34%
|
6 603
+26%
|
8 461
+28%
|
15 144
+79%
|
21 143
+40%
|
24 627
+16%
|
30 119
+22%
|
35 289
+17%
|
45 811
+30%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
60
|
60
|
61
|
61
|
65
|
65
|
65
|
65
|
65
|
64
|